{"id":"https://openalex.org/W2019370951","doi":"https://doi.org/10.1007/s002280050534","title":"Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide schedule","display_name":"Relation between unbound plasma concentrations and toxicity in a prolonged oral etoposide schedule","publication_year":1998,"publication_date":"1998-12-15","ids":{"openalex":"https://openalex.org/W2019370951","doi":"https://doi.org/10.1007/s002280050534","mag":"2019370951","pmid":"https://pubmed.ncbi.nlm.nih.gov/9923567"},"language":"en","primary_location":{"id":"doi:10.1007/s002280050534","doi":"https://doi.org/10.1007/s002280050534","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002280050534","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069411547","display_name":"Nathalie Perdaems","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"N. Perdaems","raw_affiliation_strings":["Institut Claudius-Regaud, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius-Regaud, Toulouse, France","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088902356","display_name":"Jean\u2010Marc Bachaud","orcid":"https://orcid.org/0000-0001-6361-3398","observed_orcids":["https://orcid.org/0000-0001-6361-3398"]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. M. Bachaud","raw_affiliation_strings":["Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110023714","display_name":"P Rouzaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Rouzaud","raw_affiliation_strings":["Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002444114","display_name":"M. Murris\u2010Espin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"M. Murris-Espin","raw_affiliation_strings":["Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057751279","display_name":"Christophe Hermant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Hermant","raw_affiliation_strings":["Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006848195","display_name":"Jeanne Mihura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"J. Mihura","raw_affiliation_strings":["Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075376257","display_name":"Isabelle Lochon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"I. Lochon","raw_affiliation_strings":["Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109676466","display_name":"Georges Houin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"G. Houin","raw_affiliation_strings":["Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire, 31052 Toulouse, France, , FR","institution_ids":["https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041701219","display_name":"Pierre Canal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"P. Canal","raw_affiliation_strings":["Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR","institution_ids":["https://openalex.org/I4210128666"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5002862341","display_name":"\u00c9tienne Chatelut","orcid":"https://orcid.org/0000-0002-7740-9096","observed_orcids":["https://orcid.org/0000-0002-7740-9096"]},"institutions":[{"id":"https://openalex.org/I4210128666","display_name":"Institut Claudius Regaud","ror":"https://ror.org/03pa87f90","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E. Chatelut","raw_affiliation_strings":["Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Claudius-Regaud, F-31052 Toulouse, France Tel.: 33-5-61-42-42-71 Fax: 33-5-61-42-42-74 e-mail: chatelut@icr.fnclcc.fr, , FR","institution_ids":["https://openalex.org/I4210128666"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":null,"fwci":0.2907,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.46940716,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"54","issue":"9-10","first_page":"677","last_page":"683"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.5853999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.5853999853134155,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.10019999742507935,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.055799998342990875,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9710000157356262},{"id":"https://openalex.org/keywords/oral-etoposide","display_name":"oral etoposide","score":0.8519999980926514},{"id":"https://openalex.org/keywords/unbound-plasma-concentration","display_name":"unbound plasma concentration","score":0.8600000143051147},{"id":"https://openalex.org/keywords/plasma-protein-binding","display_name":"plasma protein binding","score":0.7580000162124634},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8560000061988831},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9750000238418579},{"id":"https://openalex.org/keywords/trough-concentration","display_name":"trough concentration","score":0.4729999899864197},{"id":"https://openalex.org/keywords/sampling-schedule","display_name":"sampling schedule","score":0.4909999966621399},{"id":"https://openalex.org/keywords/nonmem","display_name":"NONMEM","score":0.7799999713897705},{"id":"https://openalex.org/keywords/individualized-dosing","display_name":"individualized dosing","score":0.5529999732971191},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.5460000038146973}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7472603917121887},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.7349892258644104},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6408869624137878},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6132851839065552},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.5607126355171204},{"id":"https://openalex.org/C76318530","wikidata":"https://www.wikidata.org/wiki/Q16833590","display_name":"Area under the curve","level":2,"score":0.4827282130718231},{"id":"https://openalex.org/C2910800852","wikidata":"https://www.wikidata.org/wiki/Q7846541","display_name":"Trough Concentration","level":3,"score":0.44829750061035156},{"id":"https://openalex.org/C3020079912","wikidata":"https://www.wikidata.org/wiki/Q3918988","display_name":"Plasma concentration","level":2,"score":0.44211047887802124},{"id":"https://openalex.org/C89838059","wikidata":"https://www.wikidata.org/wiki/Q623738","display_name":"Coefficient of variation","level":2,"score":0.4227350354194641},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38620513677597046},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3443463444709778},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3417116403579712},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3258451819419861},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.29907160997390747},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2368222177028656},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.15881234407424927}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001499","descriptor_name":"Bayes Theorem","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001798","descriptor_name":"Blood Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s002280050534","doi":"https://doi.org/10.1007/s002280050534","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s002280050534","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:9923567","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9923567","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical pharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9907000064849854,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W142928982","https://openalex.org/W1543697093","https://openalex.org/W1550111394","https://openalex.org/W1622259279","https://openalex.org/W1945936026","https://openalex.org/W1948720021","https://openalex.org/W1991042431","https://openalex.org/W1996594474","https://openalex.org/W2003143162","https://openalex.org/W2010337166","https://openalex.org/W2020693730","https://openalex.org/W2029935294","https://openalex.org/W2031520307","https://openalex.org/W2038796952","https://openalex.org/W2040178916","https://openalex.org/W2043252316","https://openalex.org/W2069547611","https://openalex.org/W2077353674","https://openalex.org/W2255570302","https://openalex.org/W2338588495","https://openalex.org/W2339248933"],"related_works":["https://openalex.org/W2277303965","https://openalex.org/W2030678629","https://openalex.org/W2019728651","https://openalex.org/W2077353674","https://openalex.org/W1996594474","https://openalex.org/W2316337442","https://openalex.org/W2030539263","https://openalex.org/W2020693730","https://openalex.org/W1948720021","https://openalex.org/W2017496719"],"abstract_inverted_index":null,"counts_by_year":[{"year":2018,"cited_by_count":2},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}